Neurocrine Biosciences
NBIX
#1734
Rank
A$17.62 B
Marketcap
A$175.58
Share price
0.83%
Change (1 day)
-2.97%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: A$220.15 AUD on 2025-12-10

Lowest end of day price: A$2.83 AUD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year Performance
2026-12.49%
2025 2.88%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$39.01 0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$327.48 1.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,471 0.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$193.01 2.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.01910-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$109.43 0.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$24.60 3.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$63.93 0.87%๐Ÿ‡ฌ๐Ÿ‡ง UK